Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Baer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Leukemia|November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaA-K Eisfeld, J Kohlschmidt, S Schwind, et al.
Cancer Research|January 13, 1998
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogeneticsM A Caligiuri, M P Strout, D Lawrence, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|September 11, 2014
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaC Niederwieser, J Kohlschmidt, S Volinia, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Leukemia|November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaA-K Eisfeld, J Kohlschmidt, S Schwind, et al.
Cancer Research|January 13, 1998
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogeneticsM A Caligiuri, M P Strout, D Lawrence, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|September 11, 2014
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaC Niederwieser, J Kohlschmidt, S Volinia, et al.
Pageof 10